Results 41 to 50 of about 5,527 (127)
Incentivizing the Utilization of Pharmacogenomics in Drug Development [PDF]
, 2012 Pharmacogenomics, the study and development of compounds according to how an individual’s genes affects the body’s response to drugs, holds enormous promise for increasing the safety and efficiency of drug development while decreasing adverse reactions ...
Koch, Valerie Gutmann
core +1 more source
Journal of Cosmetic Dermatology, Volume 24, Issue 1, January 2025.ABSTRACT Background Low‐dose oral minoxidil (LDOM) is used to treat hair loss, but the literature on its safety profile is relatively sparse. Aims Using the FDA Adverse Event Reporting System (FAERS) database, we determined signals for adverse events (AEs) with LDOM use. Methods Four sets of case/noncase study disproportionality analyses were conducted
Aditya K. Gupta +6 more
wiley +1 more source
Social pharmacology: expanding horizons [PDF]
, 2014 In the current modern and global society, social changes are in constant evolution due to scientific progress (technology, culture, customs, and hygiene) and produce the freedom in individuals to take decisions by themselves or with their doctors toward ...
Alloza y Gascón-Molins, J. L. G. +1 more
core +5 more sources
Cancer, Volume 130, Issue 24, Page 4188-4199, 15 December 2024.Abstract Comprehensive biomarker testing is a crucial requirement for the optimal treatment of advanced‐stage non–small cell lung cancer (NSCLC), with emerging relevance in the adjuvant treatment setting. To advance its goal of ensuring optimal therapy for persons diagnosed with lung cancer, the American Cancer Society National Lung Cancer Roundtable ...
Adam H. Fox +8 more
wiley +1 more source
Edaravone's Safety Profile in Acute Ischemic Stroke
Brain and Behavior, Volume 14, Issue 12, December 2024.Participants: 64 enrolled, 58 completed edaravone treatment, 4 did not finish, 2 dropped out. Demographics: Majority male (n = 35), median age 53.5 years, 81.03% with moderate stroke severity. Findings: Two patients reported headaches, one reported dizziness; no serious adverse events documented.
Laurence K. J. Batino +2 more
wiley +1 more source
An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice [PDF]
, 2012 Background: Medication registration currently requires evidence of safety and efficacy from adequately powered phase 3 studies. Pharmacovigilance (phase 4 studies, postmarketing data, adverse drug reaction reporting) provide data on more widespread and
Abernethy, Amy Pickar +4 more
core +1 more source
Food Science &Nutrition, Volume 12, Issue 12, Page 10680-10698, December 2024.The 1H‐NMR spectrum (400 MHz, CDCl3) of compound 1. The 13C NMR spectrum (100 MHz, in CDCl3) of compound 1. Structure of compound 1 as Chabamide I. Purity assessment of compound 1 in TLC plate. ABSTRACT Bangladesh is endowed with an abundance of excellent medicinal plant resources. A well‐known traditional medicinal plant Piper chaba H.
Shabiba Parvin Shandhi +9 more
wiley +1 more source
Improving the Postmarket Surveillance of Total Joint Arthroplasty Devices [PDF]
, 2011 Objective: To evaluate the FDA’s approval process and postmarket surveillance strategies for THR devices. Design: The FDA Center for Devices and Radiological Health (CDRH) 510k releasable database was used to document approved THR devices.
Brennan, Troyen Anthony +4 more
core +1 more source
DRUG THERAPY AND PREGNANCY: UNKNOWN RISKS LEAD TO HARD CHOICES [REDACTED VERSION] [PDF]
, 2012 This paper is a proposal to improve the quality of information available to pregnant patients in selecting treatment options. By providing drug companies with extended grants of exclusivity, the FDA has the ability to empower pregnant women to take ...
Goldstein, Lori M.
core
Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH [PDF]
, 2017 Clinical ...
Collins, P. +7 more
core +3 more sources